Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection

Recombinant adeno-associated virus (rAAV) vectors for gene therapy of inherited disorders have demonstrated considerable potential for molecular medicine. Recent identification of the viral receptor and coreceptors for AAV type 2 (AAV-2) has begun to explain why certain organs may demonstrate higher...

Полное описание

Библиографические подробности

Опубликовано в::	J Virol
Главные авторы:	Duan, Dongsheng, Li, Qiang, Kao, Aimee W., Yue, Yongping, Pessin, Jeffrey E., Engelhardt, John F.
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1999
Предметы:	Gene Therapy
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC113092/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10559355/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.73.12.10371-10376.1999
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!